8-166508-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001005504.1(OR4F21):c.517G>A(p.Val173Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005504.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 3AN: 44060Hom.: 0 Cov.: 6 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000545 AC: 38AN: 696850Hom.: 4 Cov.: 9 AF XY: 0.0000493 AC XY: 18AN XY: 364914
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000681 AC: 3AN: 44060Hom.: 0 Cov.: 6 AF XY: 0.0000487 AC XY: 1AN XY: 20522
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.517G>A (p.V173M) alteration is located in exon 1 (coding exon 1) of the OR4F21 gene. This alteration results from a G to A substitution at nucleotide position 517, causing the valine (V) at amino acid position 173 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at